|Year : 2017 | Volume
| Issue : 3 | Page : 158-169
Anti-inflammatory homoeopathic drug dilutions restrain lipopolysaccharide-induced release of pro-inflammatory cytokines: In vitro and in vivo evidence
Umesh B Mahajan1, Ajit K Walke1, Mahendra V Kardile1, Sameer N Goyal1, Sumit Siddharth2, Chanakya Nath Kundu2, Shreesh Ojha3, Chandragouda R Patil1
1 Department of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dhule, Maharashtra, India
2 School of Biotechnology, Cancer Biology Laboratory, KIIT School of Biotechnology, KIIT University, Bhubaneswar, Odisha, India
3 Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, University, Al-Ain, United Arab Emirates
|Date of Web Publication||15-Sep-2017|
Chanakya Nath Kundu
School of Biotechnology, Cancer Biology Laboratory, KIIT School of Biotechnology, KIIT University, Bhubaneswar, Odisha
Chandragouda R Patil
Department of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dhule, Maharashtra
Source of Support: None, Conflict of Interest: None
Context: The lipopolysaccharide (LPS)-induced cytokine release and oxidative stress are validated experimental parameters used to test anti-inflammatory activity. We investigated the effects of homoeopathic mother tinctures, 6 CH, 30 CH and 200 CH dilutions of Arnica montana, Thuja occidentalis and Bryonia alba against LPS (1 μg/ml)-induced cytokine release from RAW-264.7 cells and human whole-blood culture. Materials and Methods: For in vivo evaluations, mice were orally treated with 0.1 ml drug dilutions twice a day for 5 days followed by an intraperitoneal injection of 0.5 mg/kg LPS. After 24 h, the mice were sacrificed and serum levels of pro-inflammatory cytokines and nitric oxide were determined. The extent of oxidative stress was determined in the liver homogenates as contents of reduced glutathione, malondialdehyde, superoxide dismutase and catalase. Results: The tested drug dilutions significantly reduced in vitro LPS-induced release of tumour necrosis factor-α, interleukin-1 (IL-1) and IL-6 from the RAW-264.7 cells and human whole blood culture. Similar suppression of cytokines was evident in mice serum samples. These drugs also protected mice from the LPS-induced oxidative stress in liver tissue. Conclusions: Our findings substantiate the protective effects of Arnica, Thuja and Bryonia homoeopathic dilutions against LPS-induced cytokine elevations and oxidative stress. This study authenticates the claims of anti-inflammatory efficacy of these homoeopathic drugs.
Keywords: Cytokines, Homoeopathy, Human whole blood culture, Lipopolysaccharide, RAW-264.7
|How to cite this article:|
Mahajan UB, Walke AK, Kardile MV, Goyal SN, Siddharth S, Kundu CN, Ojha S, Patil CR. Anti-inflammatory homoeopathic drug dilutions restrain lipopolysaccharide-induced release of pro-inflammatory cytokines: In vitro and in vivo evidence. Indian J Res Homoeopathy 2017;11:158-69
|How to cite this URL:|
Mahajan UB, Walke AK, Kardile MV, Goyal SN, Siddharth S, Kundu CN, Ojha S, Patil CR. Anti-inflammatory homoeopathic drug dilutions restrain lipopolysaccharide-induced release of pro-inflammatory cytokines: In vitro and in vivo evidence. Indian J Res Homoeopathy [serial online] 2017 [cited 2020 Jan 24];11:158-69. Available from: http://www.ijrh.org/text.asp?2017/11/3/158/214843
| Introduction|| |
Homoeopathy has remained the most widespread and still a contentious mode of therapy. Homoeopathic medicines are prepared according to the methods endorsed in the homoeopathic pharmacopoeias. The therapeutic efficacy of these medicines is established through administration of the crude form of source material to healthy volunteers and recording their behavioural symptoms. Very minute doses of a homoeopathic dilution of a drug are considered to cure the diseases presenting similar symptoms which are induced by crude form of that drug in healthy volunteers. Apart from this, the medicines are selected dependent on the experiences as recorded in authoritative homoeopathic literature and to some extent by means of research.
The issues of standardisation and establishment of pharmacological profiles have never been systematically settled in Homoeopathy. However, in the last few decades, claims about the efficacy of homoeopathic medicines and their high dilutions are being revisited using validated pharmacological assays. Such studies help in critically examining and scrutinising the pharmacodynamics of the homoeopathic drugs. Validated experimental models used in establishing the pharmacodynamics of modern drugs are increasingly being used in demonstrating the efficacy of the homoeopathic drugs and their high dilutions. Recently, we have reviewed the literature on experimental proving of the anti-inflammatory activities of homoeopathic drugs and their dilutions. These studies on high dilutions of homoeopathic drugs along with continued efforts to reproduce their findings are adding to the scientific data on efficacy of homoeopathic drugs. A recent report has established the reproducibility of claims related to the effects of high dilutions of histamine on the basophil function. This study involved a strictly standardised flow cytometry protocol and showed that low and high dilutions of histamine inhibit CD203c up-regulation in anti-IgE-stimulated basophils. Such sporadic reports give impetus to further evaluations of homoeopathic drugs through validated pharmacological assays.
Anti-inflammatory drugs predominantly used in the homoeopathic practice include Arnica montana, Bryonia alba and Thuja occidentalis. These plant-derived drugs have been repeatedly tested through different pharmacological assays.,,,,
There are discrete studies reporting the anti-inflammatory efficacy of homoeopathic dilutions of these drugs. Kawakami et al. have reported the anti-inflammatory activity of Arnica 6 CH dilution in the carrageenan induced paw inflammation in rats. Bonamin et al. have further substantiated the mechanisms through which Arnica 6 CH dilution exerts anti-inflammatory activity against acute inflammation induced by carrageenan. Thuja occidentalis as homoeopathic dilution is well reported to reduce hepatitis and induce apoptosis in cancer cells. Sunila et al. have shown that the cytotoxic potential of Thuja is retained even in 30CH and 200 CH dilutions. The same group of researchers have reported the anti-tumour efficacy of ultra-high dilutions (1 M) of Thuja occidentalis, whereas Cornu et al. report the clinical ineffectiveness of Arnica and Bryonia combination against the bleeding, inflammation and ischaemia after aortic valve surgery. These contrasting claims on the proofs of efficacy of homoeopathic high dilutions present further challenges of establishing the reproducibility of such results through diverse and validated assay systems.
We investigated the anti-inflammatory efficacy of the homoeopathic dilutions (Mother tincture, 6CH, 30CH and 200 CH) of Arnica, Thuja and Bryonia in lipopolysaccharide (LPS)-induced in vivo and in vitro cytokine release assays. The LPS-induced in vitro release of cytokines from RAW-264.7 mouse macrophage cell line, whole human blood culture and LPS-induced in vivo escalation of cytokines along with oxidative stress is used as validated pharmacological assays to test anti-inflammatory activity of drugs.
| Materials and Methods|| |
Drugs and reagents
Murine macrophage cell line RAW-264.7 was obtained from ATCC, VA, USA. RPMI 1640 (Cat No. P04-18047) and foetal bovine serum (FBS) (Cat No. P30-8500) were procured from PAN Biotech, Germany. 3-(4,5-dimethylthiazol-2yl-)-2,5-diphenyl tetrazolium bromide (MTT) M2128 Cat no. 298-93-1, trypsin ethylenediaminetetraacetic acid (EDTA) (10X) and antibiotic solution (100X) were procured from HiMedia, India. LPS (L2880, Lot No. #025M4040V) and thiazolyl blue tetrazolium bromide (M2128, CAS 298-93-1) were purchased from Sigma-Aldrich, USA. ELISA Kits for tumour necrosis factor (TNF)-α (Cas No. 88-7324), interleukin-1B (IL-1B) (Cas No. 88-7013) and IL-6 (Cas No. 88-7064) were obtained from eBioscience, USA. All the homoeopathic drugs and their dilutions were obtained from Sintex International Ltd., India. All the antibodies were purchased from Santa Cruz Biotechnology, Inc.
In vitro experimental protocol
Maintenance of cell line
RAW-264.7 murine macrophage cells were grown and maintained in RPMI-1640 supplemented with 10% FBS, 1.5 mM L-glutamine and 1% antibiotic (100 U of penicillin and 10 mg streptomycin/ml in 0.9% normal saline) in a humidified atmosphere of 5% CO2 at 37°C.
Determination of non-cytotoxic concentrations of test drugs
In the present study, we determined the non-cytotoxic concentrations of 91% ethanol (used as a vehicle for preparing homoeopathic drug dilutions) and mother tinctures of test drugs. RAW-264.7 cells were co-incubated for 48 h with serial dilutions of homoeopathic mother tinctures and ethanol ranging from 100 to 10−16. As other dilutions were supposed to contain very minute traces of source drug (if any), their non-cytotoxic concentrations were taken to be similar to that of ethanol. Cells were plated in 96-well plates at a density of 10,000 cells per well. Cultures were treated with different concentrations of the homoeopathic drugs and its dilutions for 48 h. The cells were washed with 1× phosphate-buffered saline and then MTT (2.5 mg/mL) was added to each well. It was then incubated at 37°C for 6 h. Dimethyl sulphoxide solution (100 μL) was added to each well of culture plate, and the colour intensity was measured at 570 nm using a microplate reader (PowerWave XS, Biotek, USA).
Lipopolysaccharide-induced cytokines release in RAW-264.7 cells
1 × 104 RAW-264.7 cells were seeded in 96-well plate for 70% confluence. Then, the cells were stimulated with LPS (1 μg/ml) for 30 min followed by respective drug treatments. 1 μl/ml of drug dilutions was added to medium for 24 h after which the supernatant was collected and processed for cytokine using ELISA following manufacturer's protocol.
After 24 h, the supernatant from each well was harvested for determination of cytokines using ELISA. The assays were carried out in duplicates.
Lipopolysaccharide-induced cytokines release in human whole blood culture
Whole blood ex vivo stimulation is a useful tool to investigate cytokine responses to a variety of stimuli, including bacterial endotoxin (LPS). This assay was carried out as reported earlier by Thurm and Halsey. Human whole blood was collected from medial vein of a healthy volunteer into a sterile tube containing heparin (100 IU/ml). The volunteer had signed an informed consent to donate blood sample for this study and had no history of inflammatory conditions and had not taken any non-steroidal anti-inflammatory drugs for a fortnight.
The blood sample was diluted (1:5) with RPMI-1640 medium containing 10% foetal calf serum. Aliquots of 100 μl of the diluted whole blood were taken into sterile, 96-well microplate and stimulated with LPS at 1 μg/ml concentration for 30 min before addition of the homoeopathic test dilution (1 μl/ml). The microplates were incubated at 37°C for 24 h in a humidified CO2 incubator. After incubation period, the supernatant was collected by centrifugation at 3000 rpm for 10 min at room temperature and stored at −20°C and analysed for cytokine content on a subsequent day. The estimation of cytokines, IL-1β, IL-6 and TNF-α was carried out following manufacturer's protocol. The assays were carried out in duplicates.
In vivo experimental protocol
Balb/C mice (7 weeks old, weighing 28–30 g) were obtained from central animal house facility of R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, (Maharashtra). The mice were kept under standard conditions (12 h light and 12 h dark), at 22°C ± 2°C with a relative humidity of 40%–80%. They were fed a standard laboratory diet and water ad libitum. The animals were maintained in conformity with the guidelines laid down by the Committee for the Purpose of Control and Supervision of the Experiments on Animals (CPCSEA) established under the Prevention of the Cruelty to Animals Act, 1960, Ministry of Environment and Forests, Government of India. The experimental protocols were permitted by the Institutional Animal Ethics Committee of R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist-Dhule, Maharashtra, India (Protocol Approval #IAEC/CPCSEA/RCPIPER/2015/16-09). All the tests complied with the recommendations of the International Association for the Study of Pain.
Lipopolysaccharide-induced inflammation in mice
Animals were randomised by serially numbering them and then allocating them to study groups according to the sequence generated using ‘Random Number Generator’ available online as open source software Stat Trek®. The randomised mice were divided into 13 groups (n = 4). For oral administration, the test drugs and their dilutions were prepared as 10% solutions in water for injection (mixture of 0.1 ml of test drug dilution and 900 μl of water for injection). The drug treatments were given two times a day for 6 days. On the 6th day, 1 h after drug administration, the negative control group received normal saline intraperitoneally and all other groups received 0.5 mg/kg LPS solution intraperitoneally. Dexamethasone (10 mg/kg) was used as a standard drug. In this study, we included ethanol treated group (0.1 ml ethanol mixed with 900 μl of water for injection, twice a day) as a vehicle control group. After 2 h of LPS injection, blood samples were collected by retro-orbital plexus puncture method. The sera were separated and stored at −70°C for TNF-α, IL-6 and IL-1β determinations by ELISA.
Determination of cytokines production
The concentrations of TNF-α, IL-6, and IL-1β in cell culture supernatants, and mice serum samples were determined according to the manufacturer's protocol using ELISA kits.
Determination of nitric oxide production
For nitric oxide (NO) estimation, 500 μl of Griess reagent was mixed with 50 μl of serum sample and the absorbance was determined at 540 nm using Powerwave XS microplate spectrophotometer (Biotek, USA). Sodium nitrite was used as a standard for preparation of calibration curve. The NO concentration was expressed as μM of NO per mg of protein.
Preparation of liver homogenate
On the 6th day of study after blood collection, the mice were euthanised using CO2 chamber and livers were quickly isolated. For estimation of total protein content and oxidative stress parameters, 10% liver homogenates were prepared in 0.1 M Tris–HCl buffer (pH 7.4).
Determination of oxidative stress
A 10% homogenate of the liver homogenate from each mouse was prepared. The homogenate was centrifuged at 2000 g for 20 min at 4°C, and the aliquots of the supernatant were used to estimate the extent of oxidative stress. The parameters indicating oxidative stress - lipid peroxidation (LPO), reduced glutathione (GSH), activities of catalase and superoxide dismutase (SOD) - were expressed per as contents per mg of the protein present in homogenate samples.
Estimation of the extent lipid peroxidation
The liver homogenate samples were treated with 3.0 ml of 1% phosphoric acid solution and 1.0 ml of aqueous solution of 0.6% thiobarbituric acid. The reaction mixtures was heated at 80°C for 45 min, cooled in an ice bath and extracted with 4.0 ml of N-butanol. The n-butanol layer was separated and the absorbance of the pink complex formed was estimated at 532 nm as an indicator of the extent of LPO.
Estimation of reduced glutathione
The GSH content in liver homogenates was determined by treating the homogenates by DTNB method. Briefly, 20 μl of tissue homogenate was treated with 180 μl of 1 mM DTNB solution at room temperature. The optical density of the resulting yellow colour was measured at 412 nm using a microplate spectrophotometer (Powerwave XS, Biotek, USA).
Determination of the catalase activity
As reported by Gore et al., 2016, the liver homogenate (20 μl) was added to 1 ml of 10 mM H2O2 solution in the Quartz cuvette. The reduction in optical density of this mixture was monitored using microplate spectrophotometer in UV mode at 240 nm. Rate of decrease in the optical density across 3 min from the addition of the liver homogenate was taken as an indicator of the catalase activity present in the homogenate.
Estimation of superoxide dismutase activity
The superoxide dismutase activity was determined by the method reported by Dehimi et al., 2016. The liver homogenate (20 μl) was added to a mixture of 20 μl of 500 mM/l of Na2 CO3, 2 ml of 0.3% Triton X-100, 20 μl of 1.0 mM/l of EDTA, 5 ml of 10 mM/l of hydroxylamine and 178 ml of distilled water. To this mixture, 20 μl of 240 μM/l of nitroblue tetrazolium was added. The optical density of this mixture was measured at 560 nm in kinetic mode for 3 min at 1 min intervals. The rate increase in the optical density was determined as an indicator of the SOD activity.
Data were expressed as mean ± standard error mean for each group. Statistical analysis was performed using the one-way analysis of variance followed by Bonferroni's post hoc test with comparison of all column pairs. The data were analysed using a GraphPad, Prism software, version 6.0, GraphPad Software, Inc. USA. P < 0.05 was considered statistically significant.
| Results|| |
Cytotoxicity of ethanol and homoeopathic mother tinctures in RAW-264.7 cell line
The cell viability was measured by an MTT assay. We found that Arnica montana, Bryonia alba and Thuja occidentalis mother tinctures of test drugs and ethanol which is used as vehicle in homoeopathic dilutions were found to be non-cytotoxic to RAW-264.7 cells at dilutions beyond 10−4 [Figure 1]. Considering this, the effects of higher dilutions were estimated at 10−6 dilutions or 1 μl/ml of the assay medium so that cytotoxicity of ethanol and constituents of mother tinctures will not exert non-specific cellular toxicities.
|Figure 1: Estimation of non-cytotoxic concentrations of mother tinctures and ethanol in RAW-264.7 cells. (a) Ethanol and its dilutions; (b) Arnica montana mother tincture; (c) Bryonia alba mother tincture; (d) Thuja occidentalis mother tincture. The data were analysed by one-way analysis of variance. Alcohol and all the mother tinctures were diluted up to 10-16. The concentrations of all the mother tinctures up to 10-4 showed toxicity on RAW-264.7 cells; the serial dilution beyond10-4 was safe and nontoxic when studied in RAW-264.7 cells|
Click here to view
Effect of homoeopathic drugs on lipopolysaccharide-induced cytokine release from RAW-264.7 cells
LPS stimulation induced more than two-fold rise in the production of TNF-α, IL-1β and IL-6 from RAW-264.7 cells. As shown in [Figure 2], homoeopathic mother tinctures and higher dilutions of Arnica, Bryonia and Thuja significantly inhibited LPS-induced pro-inflammatory cytokine release from RAW-264.7 cells (P < 0.05). The ethanol treatment had no effect on the LPS-induced cytokine release indicating that the effects observed in case of high dilutions are not due to presence of ethanol. The inhibitory effects of higher dilutions did not show dilution-dependent effects. The suppression of cytokine release by homoeopathic dilutions was similar in all the tested dilutions. All the tested mother tinctures and high dilutions of Arnica, Bryonia and Thuja invariably suppressed the pro-inflammatory cytokine release from RAW-264.7 cells.
|Figure 2: Effect of homoeopathic mother tinctures and high dilutions of Arnica, Bryonia, Thuja on lipopolysaccharide-induced pro-inflammatory cytokine release from RAW-264.7 cells. (a) Tumour necrosis factor-α; (b) interleukin-6; (c) interleukin-1β. Data were expressed as mean ± standard error of mean (n = 4). Statistical significances were determined using one-way analysis of variance followed by Dunnett's post hoc test. ###P < 0.001 as compared to RAW control; *P < 0.05, **P < 0.01, ***P < 0.001 as compared to lipopolysaccharide control. The normal distribution of the data was tested by Bartlett's test (P < 0.05 indicated normal distribution)|
Click here to view
Effect of homoeopathic drug dilutions on lipopolysaccharide -induced cytokine release from human whole blood cultures
Similar to RAW-264.7 cells, LPS significantly induced cytokine release in whole blood culture (P < 0.001). We tested the effects of ethanol even in this assay to confirm its effect LPS-induced cytokine levels. However, unlike in case of RAW cells, ethanol suppressed the LPS-induced IL-1β and TNF-α released from the whole blood culture. Such suppressive effect was not evident in case of IL-6 and its levels were found to be similar to the LPS-stimulated control assay units. These inconsistencies in the effects of ethanol appear to cover-up the inhibitory effects of homoeopathic drugs on IL-1 and TNF-α. In the present context, it can be stated that the homoeopathic mother tinctures and high dilutions significantly inhibited the LPS-induced IL-6 release from whole blood culture (P < 0.0001) and it could not be concluded from present experiment whether the effects on IL-1 and TNF-α could be attributed to the effects of drug dilutions or ethanol [Figure 3].
|Figure 3: Effect of homoeopathic mother tinctures and high dilutions of Arnica, Bryonia, Thuja on lipopolysaccharide-induced release of cytokines from human whole blood culture. (a) Tumour necrosis factor-α; (b) interleukin-6; (c) interleukin-1β. Data were expressed as mean ± standard error of mean (n = 3). Statistical significances were determined using one-way analysis of variance followed by Dunnett's post hoc test. ###P < 0.001 as compared to blood only group, ***P < 0.001 as compared to lipopolysaccharide-treated blood culture. The normal distribution of the data was tested by Bartlett's test (P < 0.05 indicated normal distribution)|
Click here to view
Effect of homoeopathic drug dilutions on lipopolysaccharide -induced cytokine release in mice
LPS injection increased the serum levels of TNF-α, IL-6 and IL-1β almost three times as compared to the control group mice (P < 0.001). The ethanol treatment did not reduce the LPS challenge-induced cytokines. This indicates the lack of effects of ethanol on the LPS-induced cytokines in mice [Figure 4]. In congruence with the in vitro experiments, the tested homoeopathic drugs reduced LPS-induced pro-inflammatory cytokines invariably in all the tested dilutions including mother tincture (P < 0.001). The effects of all the tested dilutions of arnica were consistent and significant (P < 0.001) as compared to Thuja and Bryonia. The cytokine release inhibitory effects of Thuja and Bryonia were minimal for certain dilutions.
|Figure 4: Effect of homoeopathic drugs Arnica montana, Bryonia alba, Thuja occidentalis with its ultra-high dilutions on lipopolysaccharide-induced release of cytokines in mice. (a) Tumour necrosis factor-α; (b) interleukin-6; (c) interleukin-1β. Data were expressed as mean ± standard error of mean (n = 6). Statistical significances were determined using one-way analysis of variance followed by Dunnett's post hoc test. ###P < 0.001 as compared to normal group; *P < 0.05, **P < 0.01, ***P < 0.001 as compared to lipopolysaccharide-treated control group. The normal distribution of the data was tested by Bartlett's test (P < 0.05 indicated normal distribution)|
Click here to view
Effect of homoeopathic drugs on lipopolysaccharide-induced nitric oxide levels in serum
To investigate the effect of homoeopathic drugs Arnica, Bryonia and Thuja NO production, we measured the accumulation of nitrite in serum. Administration of LPS significantly increased serum levels of NO as compared to the control group mice. Pretreatment with the homoeopathic drug dilutions significantly reduced the LPS-induced rise in serum NO levels (P < 0.01). Of all tested drug dilutions, Thuja (200 CH) had minimal inhibitory effect on the NO levels [Table 1].
|Table 1: Effect of homoeopathic drug dilutions on nitric oxide levels and oxidative stress in lipopolysaccharide-induced oxidative stress in mice liver homogenates|
Click here to view
Effect of homoeopathic drugs on lipopolysaccharide-induced oxidative stress in mice
We used liver as a representative organ to estimate the extent of LPS-induced oxidative stress and effects of homoeopathic drugs on it. LPS injection induced a state of marked oxidative stress as evident from a significant increase in MDA level (P < 0.001) and a significant decrease in the GSH and the activities of SOD and catalase (P < 0.001) in the liver tissue homogenates. The mice treated with 6 CH dilutions of Arnica, Thuja and Bryonia were maximally protected from the induced by LPS. The protection against LPO was less prominent in case of the dilutions. The levels of GSH and the enzymatic activities SOD and catalase were significantly reduced by LPS treatment. All homoeopathic drug dilutions significantly consistently improved the GSH levels and activities of catalase and SOD. However, there was no dilution-dependent protection against oxidative stress.
| Discussion|| |
Homoeopathy is used worldwide as an economic alternative to allopathy. However, in the last few decades, homoeopathic medicines have been bitterly criticised for lack of efficacy in clinical trials. There are striking discrepancies in the proofs of efficacy even in the preclinical trials. Further, the most controversial aspect of Homoeopathy is use of drug dilutions to such an extent that just infinitesimal quantities drug substances are administered as a portion. In case of ultra-high dilutions, the drug is diluted even beyond Avogadro's number, and hence, it can be deduced that no drug is actually administered to the patient. The efforts to validate the claims on efficacy of homoeopathic drug dilution have yielded inconsistent results. Still, there are certain reports which reproducibly indicate that the biological effects of high dilutions can be demonstrated. The extensive research on the high dilutions of histamine and dexamethasone support the claims that high dilutions of drugs may possess biological activities and such activities can be proved using validated in vitro and in vivo assays., However, certain judiciously planned experimental evaluations of homoeopathic drugs and their dilutions have reproducibly proved the efficacy of homoeopathic drugs and even their high dilutions. Such scientific proofs necessitate preclinical evaluations of homoeopathic drugs through validated pharmacological assays.
The present investigation is an effort to substantiate the efficacy of three anti-inflammatory homoeopathic drugs and their high dilutions using validated experimental models of in vitro LPS-induced cytokine release from murine macrophage cell line (RAW-264.7) and whole human blood culture. The effects observed in these in vitro assays were further confirmed using in vivo LPS stimulation-induced cytokine release and oxidative stress in mice. We observed that the homoeopathic dilutions including mother tinctures, 6 CH, 30 CH and 200 CH dilutions of Arnica, Bryonia and Thuja significantly inhibited the LPS induced in vitro cytokine release from RAW-264.7 cell line and also from the whole blood culture. The in vivo evaluation proved that these dilutions significantly reduced LPS-induced cytokines and oxidative stress in mice.
In the pilot study, we studied the effects of ethanol on the RAW-264.7 to estimate the concentration of ethanol that affects the survival and activity of these cells. We used dilutions of alcohol (vehicle) ranging from 100 to 10−16 dilutions in the cell culture medium. After co-incubation of these ethanol dilutions for 48 h, we observed that the dilutions beyond 10−6 are non-toxic and do have any affect the cellular activity (cytokine release in the present case). Up to 10−4 dilutions, the ethanol exerted cytotoxic effects on RAW cells. Hence, for further studies, we diluted all the homoeopathic drug dilutions (which contained 91% ethanol as vehicle) up to 10−6 in cell culture medium so as to avoid the interference of effects of vehicle. We had used the unsuccused alcohol as vehicle in this study. It is suggested that for investigations involving homoeopathic drugs, the vehicle (ethanol) may be succused in the same manner and to the extent as the test drug dilution being studied.
Systemic inflammation is involved in the pathogenesis of many diseases. LPS is a prototypical endotoxin, which can directly activate macrophages, and induces production of inflammatory cytokines such as IL-1, IL- 6, TNF-α, and inflammatory mediators including NO and prostaglandin E2. The LPS-induced Toll-like receptor 4-dependent systemic inflammation is a classic model used in the evaluation of anti-inflammatory efficacy of drugs. The modulation of macrophage response to bacterial LPS, which is a well characterised, widely used and efficient model of evaluation of inflammatory response in vitro., LPS-induced macrophage inflammatory response involves the activation of the MAPKs ERK, p38 and JNK. MAPK activation then stimulates transcription factors including nuclear factor-κB (NF-κB) and AP-1. In particular, the p38 MAPK is an important mediator of stress-induced gene expression and plays a key role in LPS-induced signal transduction pathways, leading to cytokine synthesis. The p38 MAPK activation was reported to be involved in inducible NO synthase expression in TNF-α and IL-1-stimulated mouse astrocytes, as well as in LPS-stimulated mouse macrophages. The LPS-induced cytokine release and oxidative stress in mice are used as a method to test efficacy of drugs intended to be used in the sepsis and rheumatoid arthritis.
In the present study, we tested mother tinctures, 6 CH, 30 CH and 200 CH dilutions of Arnica, Thuja and Bryonia. The dilutions up to 30 CH are contemplated to contain at least few molecules of drug substances. However, higher dilutions can be deduced to contain no active components of the starting material. Our study results indicate that Arnica, Bryonia and Thuja dilutions even up to 200 CH exert significant inhibition of LPS-evoked cytokine release and oxidative stress. These results are in congruence with earlier sporadic reports where these drugs, as homoeopathic medicines, either alone or in combination with other drugs, are reported to exert anti-inflammatory activity. The Arnica 6 CH dilution is reported to significantly inhibit the carrageenan-induced paw oedema in rats. In this report, the authors highlight the need to consider inter-individual differences in the rats’ responses to carrageenan-induced inflammation while determining the efficacy of Arnica homoeopathic dilutions. In our study, 6 CH, 30 CH and 200 CH dilutions of Arnica significantly reduced the release of IL-1β, IL-6 and TNF-α from the LPS-stimulated RAW-264.7 cells in vitro. These effects also extended to the in vivo experiments where 5 days pre-treatment with arnica homoeopathic dilutions significantly reduced serum levels of pro-inflammatory cytokines in the LPS-challenged mice. The LPS-induced oxidative stress in the liver tissues was also significantly reduced by all the tested dilutions of Arnica. The Arnica montana extracts and its active constituents are reported to inhibit binding between NF-κB and DNA and inhibit of NF-κB-dependent gene expression., Another study has revealed that the anti-inflammatory activity of active constituents of Arnica involves inhibition of transcription factor NF-κB. The Arnica flower extracts and active constituents such as helenalin are reported to inhibit carrageenan-induced inflammation and the chronic adjuvant-induced arthritis in experimental models. Hence, it will be of great significance to check whether similar alterations in the NF-κB transcription pathway are induced by high dilutions of arnica. The findings of the present study indicate that 6CH, 30CH and 200 CH dilutions of Arnica retain the anti-inflammatory efficacies of active constituents of Arnica. As reviewed by Bonamin et al., there are certain studies which indicate that the arnica mother tincture induces local irritation and exerts phylogistic effects similar to carrageenan. The observed pro-inflammatory effects of the Arnica mother tincture and anti-inflammatory activity of the higher dilutions have been proposed to reinforce the homoeopathic principle of similitude. Recent research on effects of arnica on gene expression in macrophages proves that 1–15 CH dilutions of Arnica modulates the expression of gene related to the process of inflammation. These findings are in congruence with the observed anti-inflammatory activity of the Arnica dilutions in the present study.
Bryonia alba is an important anti-inflammatory drug widely used by homoeopaths. The major active components of the Bryonia extract are cucurbitacin glycosides and trihydroxy octadecadienoic acids. A homoeopathic formulation containing Arnica and Bryonia called Canova has been investigated through multiple in vitro and in vivo models of immune response and inflammation. This formulation containing Bryonia is reported to reduce oxidative metabolism in mouse macrophages. A randomised controlled clinical study has concluded that the treatment of chronic low-back pain due to osteoarthritis using homoeopathic Bryonia has revealed that the combination of physiotherapy and homoeopathic drug treatment has beneficial effects as compared to the placebo treatment. This study has stated the need for further investigations using larger sample sizes. Another study on the homoeopathic formulation containing Bryonia (Healwell VT-6) has proved its effectiveness in the treatment of mastitis in cattle and has projected it as an economical alternative to allopathic anti-inflammatory drugs. The finding of the present study further consolidate these claims and indicate that further investigations elucidating the molecular mechanisms of such effects of high dilutions of Bryonia might provide insights into its novel mechanisms.
Thuja occidentalis homoeopathic preparations are reported to exert antineoplastic and immunomodulatory activity in experimental models. Oral administration of 30 CH, 200 CH and 1 M dilutions of Thuja for 10 days to Balb/C mice significantly enhanced the haematological parameters including total white blood cell count, hematopoietic parameters such as bone marrow cellularity and the number of α-esterase-positive cells. The higher dilutions of Thuja increased circulating antibody titre and the number of plaque forming cells. Thuja also increased proliferation of B- and T-lymphoid cells. Another study by Mukherjee et al., 2013 reports that Thuja 30 CH dilution increases the lung cell viability in benzo(a) pyrene intoxicated mice. It reduces the oxidative stress and increases GSH content in the mouse lung cells and possesses striking ability to repair DNA damage induced by benzo(a) pyrene. A study by Lee et al. reports that aqueous extract of Thuja exerts anti-inflammatory activity in human umbilical vein endothelial cells. The possible mechanisms of this activity include reduction in the TNF-α induced expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin. In addition to this, Thuja extract also attenuated TNF-α-induced p65 NF-κB translocation into the nucleus and phosphorylation of IκB-α. These effects indicate that Thuja crude extract exerts significant anti-inflammatory activity through multiple mechanisms including inhibition of NF-κB transcription pathway.,
Though cytokine inhibitory and antioxidant effects of tested drug dilutions were significant, there were certain inconsistencies. Particularly, in case of the whole blood culture assay, we came across inhibitory effects of ethanol on LPS-induced TNF-α and IL-1β release. In the same assay medium, the concentrations of IL-6 remained unsuppressed. The differential regulation of cytokine release and variations in the patterns of IL-1β, IL-6 and TNF-α release are reported earlier.,
However, the present study results are insufficient to state how whole blood culture responds to ethanol. Such ethanol-induced differential suppression of TNF-α and IL-1 was not evident in the RAW-264.7 cell line. Hence, it can be postulated that LPS-induced cytokine release from RAW-264.7 cell line can be considered a better assay method for testing the activities of alcoholic solutions of anti-inflammatory drugs rather than whole blood culture assay.
| Conclusions|| |
These findings indicate the modulatory effects of anti-inflammatory homoeopathic drugs on LPS-induced cytokine release. These effects were not dilution dependent but consistent and reproducible in both in vitro and in vivo experiments. Our results pave the way for further investigations into the reproducibility of these effects through other experimental models and also highlight the possibility of delineating the mechanisms of anti-inflammatory effects of Arnica, Thuja and Bryonia. As LPS-induced cytokine release is mediated through different pathways including NF-kB pathway, it will be interesting to know how the homoeopathic dilutions of these drugs affect NF-kB transcriptions pathway.
We gratefully acknowledge the financial support received under the Extramural Research (EMR) scheme (23-126/2010-11/CCRH/Tech/EMR/888) from CCRH under the Ministry of AYUSH, Government of India, New Delhi, India.
Financial support and sponsorship
The authors gratefully acknowledge the financial support received under the Extramural Research (EMR) scheme (23- 126/2010-11/CCRH/Tech/EMR/888) from CCRH, under Ministry of AYUSH, Government of India, New Delhi, India.
Conflicts of interest
| References|| |
Calina DC, Docea AO, Bogdan M, Bubulica MV, Chiutu L. The pharmacists and homeopathy. Curr Health Sci J 2014;40:57-9.
Calabrese EJ, Jonas WB. Evaluating homeopathic drugs within a biomedical framework. Hum Exp Toxicol 2010;29:545-9.
Kardile MV, Patil C, Haidar A, Mahajan UB, Goyal S. Homeopathic drug standardization through biological evaluations: An untrodden avenue. Int J High Dil Res 2015;14:16-37.
Chirumbolo S, Brizzi M, Ortolani R, Vella A, Bellavite P. Inhibition of CD203c membrane up-regulation in human basophils by high dilutions of histamine: A controlled replication study. Inflamm Res 2009;58:755-64.
Olioso D, Marzotto M, Bonafini C, Brizzi M, Bellavite P. Arnica montana effects on gene expression in a human macrophage cell line. Evaluation by quantitative Real-Time PCR. Homeopathy 2016;105:131-47.
Marzotto M, Bonafini C, Olioso D, Baruzzi A, Bettinetti L, Di Leva F, et al.
Arnica montana stimulates extracellular matrix gene expression in a macrophage cell line differentiated to wound-healing phenotype. PLoS One 2016;11:e0166340.
Nazir MZ, Chandel S, Sehgal A. In vitro
screening of antioxidant potential of Thuja occidentalis
. J Chem Pharm Res 2016;8:283-6.
Mukherjee A, Sikdar S, Khuda-Bukhsh AR. Evaluation of ameliorative potential of isolated flavonol fractions from Thuja occidentalis
in lung cancer cells and in Benzo (a) pyrene induced lung toxicity in mice. Med 2016;1:1-13.
Singh R, Rajasree P, Sankar C. Screening for anti-diabetic activity of the ethanolic extract of Bryonia Alba
roots. Int J Pharm Biol Sci 2012;2:210-5.
Kawakami AP, Sato C, Cardoso TN, Bonamin LV. Inflammatory process modulation by homeopathic arnica montana 6CH: The role of individual variation. Evid Based Complement Alternat Med 2011;2011:917541.
Bonamin LV, Lagache A, Bastide M. Research on ultra-dilutions and the theory of corporeal signifiers: The follow up. In: Signals and Images. Netherlands: Springer; 2008. p. 3-25.
Frenkel M, Mishra BM, Sen S, Yang P, Pawlus A, Vence L, et al.
Cytotoxic effects of ultra-diluted remedies on breast cancer cells. Int J Oncol 2010;36:395-403.
Sunila ES, Kuttan R, Preethi KC, Kuttan G. Dynamized preparations in cell culture. Evid Based Complement Alternat Med 2009;6:257-63.
Sunila E, Kuttan G, Preethi K, Kuttan R. Effect of homeopathic medicines on transplanted tumors in mice. Asian Pac J Cancer Prev 2007;8:390-4.
Cornu C, Joseph P, Gaillard S, Bauer C, Vedrinne C, Bissery A, et al.
No effect of a homoeopathic combination of Arnica montana
and Bryonia alba
on bleeding, inflammation, and ischaemia after aortic valve surgery. Br J Clin Pharmacol 2010;69:136-42.
Schukur L, Geering B, Fussenegger M. Human whole-blood culture system for ex vivo
characterization of designer-cell function. Biotechnol Bioeng 2016;113:588-97.
Wu Q, Sun G, Yuan X, Soromou LW, Chen N, Xiong Y, et al.
Tubeimoside-1 attenuates LPS-induced inflammation in RAW 264.7 macrophages and mouse models. Immunopharmacol Immunotoxicol 2013;35:514-23.
Preet R, Siddharth S, Satapathy SR, Das S, Nayak A, Das D, et al.
Chk1 inhibitor synergizes quinacrine mediated apoptosis in breast cancer cells by compromising the base excision repair cascade. Biochem Pharmacol 2016;105:23-33.
Thurm CW, Halsey JF. Measurement of cytokine production using whole blood. Curr Protoc Immunol 2005;7(7):18B.
Broekman MM, Roelofs HM, Hoentjen F, Wiegertjes R, Stoel N, Joosten LA, et al
. Mo1739 LPS stimulated whole blood cytokine production and the association with disease characteristics in patients with quiescent Crohn's Disease. Gastroenterology 2015;148:S-699.
Kim WH, An HJ, Kim JY, Gwon MG, Gu H, Park JB, et al.
Bee venom inhibits porphyromonas gingivalis lipopolysaccharides-induced pro-inflammatory cytokines through suppression of NF-κB and AP-1 signaling pathways. Molecules 2016;21. pii: E1508.
Tripathi YB, Sharma AK, Shukla R, Nidhi P, Gangwar M, Sinha AS. Antimicrobial and anti-inflammatory activity of press cake of Jatropha curcas. Appl Microbiol 2016;2:1-6.
Jiang W, Luo F, Lu Q, Liu J, Li P, Wang X, et al.
The protective effect of trillin LPS-induced acute lung injury by the regulations of inflammation and oxidative state. Chem Biol Interact 2016;243:127-34.
Nardi GM, Farias Januario AG, Freire CG, Megiolaro F, Schneider K, Perazzoli MR, et al.
Anti-inflammatory activity of berry fruits in mice model of inflammation is based on oxidative stress modulation. Pharmacognosy Res 2016;8:S42-9.
Gore PR, Prajapati CP, Mahajan UB, Goyal SN, Belemkar S, Ojha S, et al.
Protective effect of thymoquinone against cyclophosphamide-induced hemorrhagic cystitis through inhibiting DNA damage and upregulation of Nrf2 expression. Int J Biol Sci 2016;12:944-53.
Dehimi K, Speciale A, Saija A, Dahamna S, Raciti R, Cimino F, et al.
Antioxidant and anti-inflammatory properties of Algerian thymelaea
microphylla coss. and dur. extracts. Pharmacogn Mag 2016;12:203-10.
Bonamin LV, de Moraes CL, Sanches F, Cardoso TN, Sato C, Duran Filho C, et al.
Rats born to mothers treated with dexamethasone 15 cH present changes in modulation of inflammatory process. Evid Based Complement Alternat Med 2012;2012:710923.
Bonamin LV, Martinho KS, Nina AL, Caviglia F, Do Rio RG. Very high dilutions of dexamethasone inhibit its pharmacological effects in vivo
. Br Homeopath J 2001;90:198-203.
Rossol M, Heine H, Meusch U, Quandt D, Klein C, Sweet MJ, et al.
LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol 2011;31:379-446.
Lawrence T, Willoughby DA, Gilroy DW. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2002;2:787-95.
Juskewitch JE, Knudsen BE, Platt JL, Nath KA, Knutson KL, Brunn GJ, et al.
LPS-induced murine systemic inflammation is driven by parenchymal cell activation and exclusively predicted by early MCP-1 plasma levels. Am J Pathol 2012;180:32-40.
Ji G, Zhang Y, Yang Q, Cheng S, Hao J, Zhao X, et al.
Genistein suppresses LPS-induced inflammatory response through inhibiting NF-κB following AMP kinase activation in RAW 264.7 macrophages. PLoS One 2012;7:e53101.
Gauley J, Pisetsky DS. The release of microparticles by RAW 264.7 macrophage cells stimulated with TLR ligands. J Leukoc Biol 2010;87:1115-23.
Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001;13:85-94.
Youn CK, Park SJ, Lee MY, Cha MJ, Kim OH, You HJ, et al.
Silibinin inhibits LPS-induced macrophage activation by blocking p38 MAPK in RAW 264.7 cells. Biomol Ther (Seoul) 2013;21:258-63.
Hall IH, Starnes CO Jr., Lee KH, Waddell TG. Mode of action of sesquiterpene lactones as anti-inflammatory agents. J Pharm Sci 1980;69:537-43.
Gertsch J, Sticher O, Schmidt T, Heilmann J. Influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in Jurkat T cells and human peripheral blood cells: Anti-inflammatory and cytotoxic effects. Biochem Pharmacol 2003;66:2141-53.
Lyss G, Knorre A, Schmidt TJ, Pahl HL, Merfort I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J Biol Chem 1998;273:33508-16.
Hall IH, Lee KH, Starnes CO, Sumida Y, Wu RY, Waddell TG, et al.
Anti-inflammatory activity of sesquiterpene lactones and related compounds. J Pharm Sci 1979;68:537-42.
de Oliveira CC, de Oliveira SM, Godoy LM, Gabardo J, Buchi Dde F. Canova, a brazilian medical formulation, alters oxidative metabolism of mice macrophages. J Infect 2006;52:420-32.
Debora O, Marta M, Clara B, Maurizio B, Paolo B. Arnica montana effects on gene expression in a human macrophage cell line. Evaluation by quantitative Real-Time PCR. Homeopathy 2016;105(2):1-17.
Morris M, Pellow J, Solomon EM, Tsele-Tebakang T. Physiotherapy and a homeopathic complex for chronic low-back pain due to osteoarthritis: A randomized, controlled pilot study. Altern Ther Health Med 2016;22:48-56.
Varshney JP, Naresh R. Comparative efficacy of homeopathic and allopathic systems of medicine in the management of clinical mastitis of indian dairy cows. Homeopathy 2005;94:81-5.
Remya V, Kuttan G. Homeopathic remedies with antineoplastic properties have immunomodulatory effects in experimental animals. Homeopathy 2015;104:211-9.
Mukherjee A, Boujedaini N, Khuda-Bukhsh AR. Homeopathic Thuja
30C ameliorates benzo(a)pyrene-induced DNA damage, stress and viability of perfused lung cells of mice in vitro
. J Integr Med 2013;11:397-404.
Lee YJ, Hwang SM, Yoon JJ, Lee SM, Kyung EH, Kim JS, et al.
Inhibitory effect of Thuja orientalis
on TNF-α-induced vascular inflammation. Phytother Res 2010;24:1489-95.
Sharif O, Bolshakov VN, Raines S, Newham P, Perkins ND. Transcriptional profiling of the LPS induced NF-kappaB response in macrophages. BMC Immunol 2007;8:1.
D'Hellencourt CL, Diaw L, Cornillet P, Guenounou M. Differential regulation of TNF alpha, IL-1 beta, IL-6, IL-8, TNF beta, and IL-10 by pentoxifylline. Int J Immunopharmacol 1996;18:739-48.
Gervassi A, Alderson MR, Suchland R, Maisonneuve JF, Grabstein KH, Probst P, et al.
Differential regulation of inflammatory cytokine secretion by human dendritic cells upon Chlamydia trachomatis
infection. Infect Immun 2004;72:7231-9.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]